Company Profiles

driven by the PitchBook Platform

BliNK Therapeutics

Description

Developer of novel platform to generate therapeutic and diagnostic monoclonal antibodies towards clinically relevant targets. The company has developed a technology which provides a new way to activate the immune system's B cells to produce antibodies in response to a specific antigen.

2011

Founded

PRIVATE

Status

1-10

Employees

Accelerator/Inc

Latest Deal Type

$2.54M

Total Amount Raised

3

Investors

Description

Developer of novel platform to generate therapeutic and diagnostic monoclonal antibodies towards clinically relevant targets. The company has developed a technology which provides a new way to activate the immune system's B cells to produce antibodies in response to a specific antigen.

Website:

www.blinktherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

London England
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore BliNK Therapeutics's full profile, request a free trial.

BliNK Therapeutics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

BliNK Therapeutics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

BliNK Therapeutics Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Cancer Research TechnologyVenture CapitalMinority000 0000000 0000
Kurma PartnersVenture CapitalMinority000 0000000 0000
Stevenage Bioscience CatalystAccelerator/Incubator000 0000000 0000
Cancer Research Technology Venture Capital
Kurma Partners Venture Capital
Stevenage Bioscience Catalyst Accelerator/Incubator

BliNK Therapeutics Board Members (2)

NameRepresentingRoleSinceContact
Info
Irina Staatz-GranzerSelfChairman000 0000
Nicola Beltraminelli Ph.DSelfBoard Member000 0000
Irina Staatz-Granzer Chairman Self
Nicola Beltraminelli Ph.D Board Member Self
Request full access to PitchBook